Global confluence of infectious and non-communicable diseases - The case of type 2 diabetes

Preventive Medicine

Volumn 57, Issue 3, 2013, Pages 149-151

  Magee, M J ^a   Narayan, K M Venkat ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SAQUINAVIR; STAVUDINE;

ADAPTIVE IMMUNITY; BACTERICIDAL ACTIVITY; DEATH; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; HEALTH AUXILIARY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGLYCEMIA; INFECTION; INNATE IMMUNITY; NON COMMUNICABLE DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PRIORITY JOURNAL; RELAPSE; TREATMENT FAILURE; TUBERCULOSIS;

COMMUNICABLE DISEASES; DIABETES MELLITUS; GROUP B STREPTOCOCCUS; HIV; TUBERCULOSIS;

COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; DIABETES MELLITUS, TYPE 2; HUMANS; WORLD HEALTH;

EID: 84881611284     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2013.05.027     Document Type: Note

References (12)

1. Baker M.A., Harries A.D., Jeon C.Y., et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med. 2011, 9:81.
2. Balakrishnan S., Vijayan S., Nair S., et al. High diabetes prevalence among tuberculosis cases in Kerala, India. PLoS One 2012, 7:e46502.
3. Horton R. GBD 2010: understanding disease, injury, and risk. Lancet 2013, 380:2053-2054.
4. Naing C., Mak J.W., Wai N., Maung M. Diabetes and infections-hepatitis C: is there type 2 diabetes excess in hepatitis C infection?. Curr. Diab. Rep. 2013, 13(3):428-434.
5. Phares C.R., Lynfield R., Farley M.M., et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008, 299:2056-2065.
6. Rasmussen L.D., Mathiesen E.R., Kronborg G., Pedersen C., Gerstoft J., Obel N. Risk of diabetes mellitus in persons with and without HIV: a Danish nationwide population-based cohort study. PLoS One 2012, 7:e44575.
7. Skoff T.H., Farley M.M., Petit S., et al. Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. Clin. Infect. Dis. 2009, 49:85-92.
8. Stevenson C.R., Forouhi N.G., Roglic G., et al. Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence. BMC Publ. Health 2007, 7:234.
9. Sullivan T., Ben Amor Y. The co-management of tuberculosis and diabetes: challenges and opportunities in the developing world. PLoS Med. 2012, 9:e1001269.
10. Thomsen R.W., Riis A.H., Kjeldsen S., Schonheyder H.C. Impact of diabetes and poor glycaemic control on risk of bacteraemia with haemolytic streptococci groups A, B, and G. J. Infect. 2011, 63:8-16.
11. Wang C.S., Wang S.T., Yao W.J., Chang T.T., Chou P. Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study. Am. J. Epidemiol. 2007, 166:196-203.
12. White D.L., Ratziu V., El-Serag H.B. Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. J. Hepatol. 2008, 49:831-844.